Actarit
CAS No. 18699-02-0
Actarit( MS-932 | NSC 170317 )
Catalog No. M12889 CAS No. 18699-02-0
Actarit is an anti-inflammatory drug developed in Japan for use in rheumatoid arthritis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | 29 | In Stock |
|
| 500MG | 45 | In Stock |
|
| 1G | 65 | In Stock |
|
Biological Information
-
Product NameActarit
-
NoteResearch use only, not for human use.
-
Brief DescriptionActarit is an anti-inflammatory drug developed in Japan for use in rheumatoid arthritis.
-
DescriptionActarit is an anti-inflammatory drug developed in Japan for use in rheumatoid arthritis.
-
In Vitro——
-
In Vivo——
-
SynonymsMS-932 | NSC 170317
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number18699-02-0
-
Formula Weight193.2
-
Molecular FormulaC10H11NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(O)CC1=CC=C(NC(C)=O)C=C1
-
Chemical Name2-(4-acetamidophenyl)acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
MPEP hydrochloride
MPEP hydrochloride is an effective and highly specific non-competitive antagonist at the mGlu5 receptor subtype (IC50: 36 nM).
-
Neuropeptide W-30 (h...
Neuropeptide W-30 (human) is an important stress mediator in the central nervous system that modulates the hypothalamus-pituitary-adrenal (HPA) axis and sympathetic outflow. Neuropeptide W-30 (human) is an endogenous ligand for the two structurally related orphan G-protein-coupled receptors (GPCRs) GPR7 and GPR8. Neuropeptide W-30 (human)activates and binds to both GPR7 and GPR8 at similar effective doses.
-
LtaS-IN-1
LtaS-IN-1 is an effective inhibitor of Lipoteichoic acid synthesis in multidrug-resistant (MDR) E. faecium and by altering the cell wall morphology.
Cart
sales@molnova.com